Totally Agree.
An extract from the AGM
Expect the following
CREATING VALUE - KEY INFLECTION POINTS
Immunotherapies
-HSV-2 Phase II interim data end 2015
-Additional HSV-2 Phase II data in CY 2016
-Complete preclinical HPV studies
-Initiation of Ian Frazer's next HPV product as a treatment against HPV and Cervical Cancer into Phase 1B CY2016
DEFINITION OF 'INFLECTION POINT'
An event that results in a significant change in the progress of a company, industry, sector, economy or geopolitical situation. An inflection point can be considered a turning point after which a dramatic change, with either positive or negative results, is expected to result. Companies, industries, sectors and economies are dynamic and constantly evolving. Inflection points are more significant than the small day-to-day progress that is made and the effects of the change are often well-known and widespread.
Guess what end of 2015 is not far away....
Totally Agree. An extract from the AGM Expect the following...
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.97 |
Change
-0.235(1.29%) |
Mkt cap ! $345.3M | |||
| Open | High | Low | Value | Volume |
| $18.09 | $18.09 | $17.88 | $1.182K | 66 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 60 | $17.88 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.05 | 554 | 1 |
View Market Depth
| Last trade - 14.30pm 10/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |